No, I didn't miss your point and it's too late to change it. You said "CYDY does not have the infrastructure to bring leronlimab to market, we all know that. There would have to be a third party involved". You can't be any clearer than that. You were wrong - plain and simple.
Quote:
I think you missed mine. 100% of revenue doesn't go to CYDY
(1)
(0)
CytoDyn Inc (CYDY) Stock Research Links
My comments are just my opinions and should NOT be taken as investment advice.